Beyfortus is used for the prevention of respiratory syncytial virus lower respiratory tract disease in newborns and infants born during or entering their first RSV season.
Pharmacies and healthcare providers can establish electronic connections to the NCIR to improve patient outcomes and streamline reporting of immunizations.